Myriad
Order a GENETIC TESTING KIT
Mutation Prevalence Tables
Hereditary Cancers Genetic Testing Reimbursement/Privacy Resources About Myriad
FAP Overview
Identifying Patients
Cancer Risks
Medical Management
Benefits of Testing
Family Matters FAQs
Search
Site Map
Contact Myriad
Home
Identifying Patients At-Risk for Adenomatous Polyposis Syndromes
Increasingly, direct genetic testing for germline mutations in APC or MYH genes is used to diagnose adenomatous polyposis syndromes in those with a suggestive personal or family history. Individuals who should be offered genetic testing for adenomatous polyposis syndromes are:32
Individuals who are clinically affected with FAP (100 or more colorectal adenomas)
Individuals with "multiple" colorectal adenomas (usually 10 or more cumulative adenomas)
Relatives of APC or MYH mutation carriers, as appropriate

Genetic testing will allow you to identify patients with adenomatous polyposis syndromes and then adjust their medical management accordingly.
» Adenomatous Polyposis Syndromes: Cancer Risks


COLARIS is a genetic test for adenomatous polyposis syndromes
A genetic test for adenomatous polyposis syndromes